University of California San Francisco
Give to UCSF
UCSF has 19 registered teams at this year's AIDS Walk San Francisco. They hope to beat last year's total of $71,573, the third highest total among all Bay Area groups. They set a new goal of $75,000 this year.
A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
New research from UCSF and the San Francisco AIDS Foundation has found that clients participating in a harm-reduction substance use treatment program, the Stonewall Project, decrease their use of stimulants, such as methamphetamine, and reduce their sexual risk behavior.
Research led by scientists at the UCSF-affiliated Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS. Further, they have identified an existing anti-inflammatory drug that in laboratory tests blocks the death of these cells.
A new study provides further proof that regular use of the the HIV antiretroviral drug Truvada can reduce one’s risk for contracting HIV – without increasing sexual risk behavior.
Over more than two decades in Africa, UCSF researchers have approached their scientific work with a dual aim: treat disease while helping to sustainably build up the local health care system.
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
On a notoriously chilly foggy day in San Francisco, UCSF teams raised more than $53,000 in AIDS Walk San Francisco on July 21.
A new study by UCSF researchers points to changes in intestinal bacteria as a possible explanation for why successfully treated HIV patients nonetheless experience life-shortening chronic diseases.
Two veteran UCSF doctors who have been battling the AIDS epidemic for decades retraced past efforts and described their ongoing quest for a cure for HIV in the Academic Senate’s Third Annual Faculty Research Lecture.
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.
UCSF researchers found that poor HIV-infected individuals living in San Francisco are significantly more likely to visit emergency rooms and to have hospital stays if they lack access to food of sufficient quality and quantity for a healthy life.
<p>A proposed new treatment to help HIV/AIDS patients suffering from Kaposi’s sarcoma, the most common form of cancer in people with HIV, is now one step closer to becoming a reality thanks to a program that supports promising early-stage research.</p>
Adults with HIV in rural sub-Saharan Africa who receive antiretroviral drugs early in their infection may reap benefits in their ability to work and their children's ability to stay in school, according to a first-of-its-kind clinical study in Uganda that compared socioeconomic outcomes with CD4+ counts — a standard measure of health status for people with HIV.